Navigation Links
TopoTarget Successfully Buys Back Full Control of Belinostat
Date:4/22/2008

in combination with the standard therapies Carboplatinum and Paclitaxel (the so-called BelCaP combination).

Financial update and updated 2008 guidance With the consolidation of the global rights, TopoTarget is entering a new phase of development. Today's deal strengthens TopoTarget's position in its pursuit of a large pharma partner. To aid this process the company has assembled a highly-skilled international business development team, and has an international board of directors with strong industry networks.

TopoTarget expects to strengthen its financial resources through increasing revenues from Savene(R)/Totect(R) and actively pursuing partnership opportunities for other projects in its broad pipeline.

TopoTarget now forecasts a 2008 pre-tax loss in the range of DKK 235-255 million compared to the guidance for 2008 pre-tax loss of DKK 175-195 million given in the Annual Report 2007.

Issue of shares to Curagen Corporation As part of the deal, TopoTarget has agreed to issue a total of 5 million TopoTarget shares of nominal DKK 1 each to CuraGen Corporation. The shares will be issued without preemptive subscription rights for the existing shareholders of TopoTarget in a directed issue of shares to CuraGen Corporation. The resolution to issue the shares will be made by the board of directors of TopoTarget, as soon as possible, pursuant to the authorization contained in Article 7 of TopoTarget's Articles of Association whereby the board of directors has been authorized - until 1 May 2010 - at one or more times to increase Topotarget's share capital with up to nominal DKK 5,000,000. The issuance of the 5 million shares will be made pursuant to applicable exemptions from prospectus requirements. In connection with the resolution to issue the shares, TopoTarget will publish a separate company announcement as required under the rules of the OMX Nordic Exchange Copenhagen A/S.

Webcast conference call details: TopoTarget management will ho
'/>"/>

SOURCE TopoTarget A/S
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. CuraGen and TopoTarget Announce Initiation of an NCI-sponsored Phase II Clinical Trial of Belinostat for Thymoma and Thymic Carcinoma
2. Bayer HealthCare Affiliate MEDRAD Successfully Completes Tender Offer for Shares of Possis Medical; Announces Subsequent Offering Period
3. SBT Acquisition Inc. Successfully Completes Tender Offer for Shares of Lifecore Biomedical, Inc.
4. Phase I Safety and Tolerability Study With EVT 302 Successfully Completed
5. ARIUS announces cancer stem cell antibody program successfully completes first toxicology study
6. Life on Mars pregnancy test successfully launched
7. EpiStem Successfully Complete First Year of Mucositis Tests for NIH Biodefence Programme
8. ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc.
9. Citrate appears to control buckyball clumping but environmental concerns remain
10. Vela Laboratories Receives the GMP Certificate for Its Analytical and Quality Control Laboratories
11. CSC Continues Support of Centers for Disease Control and Prevention Through New Task Order
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 This webinar will ... and clinical safety assessment in biosimilars. , Regulatory frameworks ... biosimilar drug development, however the complex nature of biopharmaceuticals ... safety and efficacy extremely challenging. Based on the specific ...
(Date:1/15/2014)... 2014 DTS Language Services, Inc . ... Portal for Life Science organizations who need document translations. ... matter of their documents in advance with a selection of ... of translations, often a critical factor in clinical and scientific ...
(Date:1/14/2014)... 14, 2014 Date: Friday, April 11, 2014 ... Country Club, 1360 Almshouse Road, Warrington, Pa. , ... solely dedicated to finding a cure for hepatitis B and ... host its annual Crystal Ball on Friday, April 11 at ...
(Date:1/14/2014)... EquitiesIQ, a leading informational research provider, ... is an emerging biomedical company acquiring, developing, manufacturing, and ... , Free report download: http://equitiesiq.com/reports/alliqua/ , In ... team and Board, which launched the company’s new strategy ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... conductivities seen in metal wires, and that may light up ... researchers. A Rice lab made such a cable from ... standard line voltage -- a true test of the novel ... the future. The work appears this week in ...
... Sept. 7, 2011 Cellectis (Alternext: ALCLS), ... that its nuclease production capacity has increased ... Industrialization of the nuclease manufacturing gives Cellectis ... subsidiary of Cellectis, the potential to supply ...
... 2011 Ardea Biosciences, Inc. (Nasdaq: RDEA ) ... with the U.S. Food and Drug Administration (FDA) and successfully ... lesinurad Phase 3 development plan: the overall size and design ... the total safety database proposed for NDA filing, manufacturing plans ...
Cached Biology Technology:Rice researchers power line-voltage light bulb with nanotube wire 2Cellectis Announces a Ten-Fold Increase in Nuclease Production Capacity in 2011 2Ardea Biosciences Announces Positive End-of-Phase 2 Meetings with FDA for Lesinurad 2Ardea Biosciences Announces Positive End-of-Phase 2 Meetings with FDA for Lesinurad 3Ardea Biosciences Announces Positive End-of-Phase 2 Meetings with FDA for Lesinurad 4Ardea Biosciences Announces Positive End-of-Phase 2 Meetings with FDA for Lesinurad 5
(Date:4/17/2014)... Kansas State University engineer has developed a patented ... improvised explosive devices. The same technique could help ... Steven M. and Kay L. Theede chair in ... engineering, and his research team have created a ... in car trunks. The distance detection method ...
(Date:4/17/2014)... that devastate honeybees in Europe, Asia and the United ... appear to be impacting native honeybee populations at this ... invasive pests include including Nosema microsporidia and ... to be resilient to these invasive pests, which suggests ... in Europe, Asia and the United States currently are ...
(Date:4/17/2014)... Press journal Current Biology on April 17 ... lives. The Brazilian insects, which represent four distinct but ... the first example of an animal with sex-reversed genitalia. ... several different animals, Neotrogla is the only ... says Kazunori Yoshizawa from Hokkaido University in Japan. , ...
Breaking Biology News(10 mins):Patented research remotely detects nitrogen-rich explosives 2East African honeybees are safe from invasive pests… for now 2East African honeybees are safe from invasive pests… for now 3In sex-reversed cave insects, females have the penises 2
... This release is available in Spanish . ... checking the animals, eye color, according to an Agricultural Research ... ARS Dale Bumpers Small Farms Research Center in Booneville, Ark., ... collaboration with scientists, veterinarians, and extension agents from the Southern ...
... JERUSALEM , July 6, 2010 IDenta Corp.,(PINKSHEETS: IDTA) CEO Yaacov Shoham today issued a ... The IDenta,s BTK- Bullet Hole Testing Kit was ... , , To see ... http://www.lasvegassun.com/news/2008/jul/08/gee-whiz-packed-metro-csi-tru , ...
... 2010 A new computer data compression technique called Genomic ... will allow genetic researchers and others to store, analyze and ... lower cost. Created specifically for genomic sequencing data, the ... in a paper published today in the journal Bioinformatics ...
Cached Biology News:For lambs, a pasture a week keeps blood suckers away 2International Drug & Explosives Detection Company IDenta Corp Reports on BTK- Bullet Hole Testing Kit 2International Drug & Explosives Detection Company IDenta Corp Reports on BTK- Bullet Hole Testing Kit 3New TGen technology reduces storage needs and costs for genomic data 2New TGen technology reduces storage needs and costs for genomic data 3
Request Info...
Guinea Pig Complement...
Collected from 8-12 week-old New Zealand or Californian rabbits....
Enables rapid purification of double-stranded DNA fragments = 200 bp, including, for example, PCR reaction products, DNA fragments obtained in restriction enzyme digests, or double-stranded cDNA...
Biology Products: